Vein of Galen aneurysmal malformation: rationalizing medical management of neonatal heart failure

Melinda Cory, Phillippe Durand, Rafael Sillero, Luc Morin, Rashmin Savani, Lina Chalak, Dimitrios Angeles
The University of Texas Southwestern Medical Center. Paris-Saclay University Hospitals, Bicêtre Medical Centre and Assistance Publique-Hospitaux de Paris.
United States and France

Pediatric Research
Pediatr Res 2023; 93: 39-48
DOI: 10.1038/s41390-022-02064-1

Abstract
Neonates who present in high output heart failure secondary to vein of Galen aneurysmal malformation can be difficult to manage medically due to the complex physiology that results from the large shunt through the malformation. Though the cardiac function is often normal, right ventricular dilation, severe pulmonary hypertension, and systemic steal can result in inadequate organ perfusion and shock. This report recommends medical management for stabilization of neonates prior to definitive management with endovascular embolization.
IMPACT: Vein of Galen aneurysmal malformation (VGAM) is a rare intracranial arteriovenous malformation, which can present in the neonatal period with high output heart failure. Heart failure secondary to VGAM is often difficult to manage and is associated with high mortality and morbidity. Despite optimal medical management, many patients require urgent endovascular embolization for stabilization of their heart failure. This report offers discrete recommendations that can be used by clinicians as guidelines for the medical management of heart failure in newborns with VGAM.

Category
Class I. Pulmonary Hypertension Associated with Congenital Cardiovascular Disease

Age Focus: Pediatric Pulmonary Vascular Disease

Fresh or Filed Publication: Filed (PHiled). Greater than 1-2 years since publication

Article Access
Free PDF File or Full Text Article Available Through PubMed or DOI: No

Scroll to Top